ZTS

ZOETIS
D

ZTS

162.900
USD
-1.85
(-1.12%)
Market Open
Volume
32,772
EPS
6
Div Yield
1.05
P/E
31
Market Cap
73,481,245,342
OverviewSignalsIdeasNews
Signals
Related Instruments
    NEOUSD
    NEOUSD
    -0.006
    (-0.04%)
    14.264 USD
    AMGN
    AMGN
    -1.48
    (-0.56%)
    261.55 USD
    BMY
    BMY
    0.040
    (0.07%)
    57.320 USD
    IDXX
    IDXX
    -2.07
    (-0.50%)
    410.38 USD
    MRK
    MRK
    0.610
    (0.62%)
    98.850 USD
    N
    NEO
    0.225
    (1.37%)
    16.630 USD
    NVS
    NVS
    0.500
    (0.52%)
    97.505 USD
    PFE
    PFE
    0.020
    (0.08%)
    26.390 USD
    SNY
    SNY
    0.290
    (0.61%)
    47.960 USD
    More
News

Title: ZOETIS

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.